US › Healthcare

Scilex Holding Company (SCLX)

US · Healthcare · Drug Manufacturers - General

$5.37+3.87%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$7.6M

Revenue YoY

-22.8%

Net profit

$-113.5M

EPS

$-16.65

Net margin

-1,485.2%

Key statistics

Market cap

$36.4M

Forward P/E

5.6

P/B

28.85

Book value

$-43.83

EPS (TTM)

$-52.66

52-week high

$21.34

52-week low

$2.62

50-day MA

$6.71

200-day MA

$6.32

Beta

1.72

Analyst view

Analysts rate Scilex Holding Company a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $490.00.

Shareholding

Insiders

11.67%

Institutions

8.53%

Largest institutional holders

Fund	Stake
Armistice Capital, LLC	4.23%
Vanguard Capital Management, LLC	3.75%
BlackRock Inc	1.46%
Vanguard Fiduciary Trust Co	0.56%
Renaissance Technologies Corp	0.52%
State Street Corp	0.50%
Citadel Advisors Llc	0.39%
XTX Topco Ltd	0.32%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Scilex Holding Company — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.